Grant

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

CountryUnited States
Deadline2027-02-03 (73 days left)
Published2024-12-05
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-25-026. CFDA: 93.840, 93.838, 93.233, 93.837, 93.839

The buyer, the value, the full description and the link to the official notice are available with a free account.